| Primary |
| Asthma |
46.9% |
| Chronic Obstructive Pulmonary Disease |
17.2% |
| Hypertension |
4.8% |
| Dyspnoea |
4.5% |
| Bronchitis |
3.2% |
| Emphysema |
2.8% |
| Hypersensitivity |
2.4% |
| Cough |
2.2% |
| Bronchospasm |
1.9% |
| Product Used For Unknown Indication |
1.8% |
| Wheezing |
1.6% |
| Pain |
1.5% |
| Depression |
1.4% |
| Diabetes Mellitus |
1.4% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Asthma Exercise Induced |
1.2% |
| Anxiety |
1.0% |
| Cardiac Disorder |
0.9% |
| Prophylaxis Against Bronchospasm |
0.8% |
| Vitamin Supplementation |
0.7% |
|
| Drug Ineffective |
32.7% |
| Dyspnoea |
11.1% |
| Pharmaceutical Product Complaint |
10.1% |
| Product Quality Issue |
9.9% |
| Wheezing |
4.5% |
| Drug Effect Decreased |
4.4% |
| Asthma |
2.8% |
| Product Substitution Issue |
2.5% |
| Throat Irritation |
2.5% |
| Tremor |
2.4% |
| Cough |
2.3% |
| Death |
2.3% |
| Device Malfunction |
2.1% |
| Pneumonia |
1.8% |
| Therapeutic Response Unexpected With Drug Substitution |
1.8% |
| Inappropriate Schedule Of Drug Administration |
1.7% |
| Breath Alcohol Test Positive |
1.3% |
| Vomiting |
1.3% |
| Headache |
1.3% |
| Heart Rate Increased |
1.1% |
|
| Secondary |
| Asthma |
29.0% |
| Chronic Obstructive Pulmonary Disease |
22.2% |
| Emphysema |
7.9% |
| Product Used For Unknown Indication |
6.3% |
| Dyspnoea |
5.3% |
| Bronchitis |
3.3% |
| Cardiac Disorder |
3.3% |
| Hypertension |
2.8% |
| Hypersensitivity |
2.5% |
| Cough |
2.4% |
| Bronchitis Chronic |
2.1% |
| Depression |
2.1% |
| Drug Use For Unknown Indication |
2.1% |
| Bronchospasm |
1.5% |
| Wheezing |
1.5% |
| Diabetes Mellitus |
1.4% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Pain |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Gastric Disorder |
1.0% |
|
| Drug Ineffective |
16.2% |
| Product Quality Issue |
14.9% |
| Dyspnoea |
9.1% |
| Wheezing |
7.1% |
| Pharmaceutical Product Complaint |
5.8% |
| Asthma |
5.2% |
| Pneumonia |
5.2% |
| Somnolence |
4.5% |
| Alopecia |
3.2% |
| Drug Effect Decreased |
3.2% |
| Inappropriate Schedule Of Drug Administration |
3.2% |
| Cough |
2.6% |
| Death |
2.6% |
| Headache |
2.6% |
| Medication Error |
2.6% |
| Myocardial Infarction |
2.6% |
| Tremor |
2.6% |
| Weight Increased |
2.6% |
| Feeling Abnormal |
1.9% |
| Hypertrophic Cardiomyopathy |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.9% |
| Asthma |
17.3% |
| Chronic Obstructive Pulmonary Disease |
13.5% |
| Drug Use For Unknown Indication |
7.3% |
| Hypertension |
5.7% |
| Pain |
5.1% |
| Depression |
3.1% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Anxiety |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Diabetes Mellitus |
2.4% |
| Contraception |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Emphysema |
2.1% |
| Hypersensitivity |
2.1% |
| Dyspnoea |
2.0% |
| Osteoporosis |
1.5% |
| Smoking Cessation Therapy |
1.5% |
| Prophylaxis |
1.4% |
| Back Pain |
1.2% |
|
| Dyspnoea |
14.5% |
| Product Quality Issue |
8.8% |
| Drug Ineffective |
8.5% |
| Vomiting |
6.6% |
| Pulmonary Embolism |
5.9% |
| Pneumonia |
5.8% |
| Pain |
5.7% |
| Wheezing |
5.0% |
| Asthma |
4.3% |
| Death |
4.3% |
| Weight Decreased |
4.3% |
| Weight Increased |
4.0% |
| Nausea |
3.6% |
| Dysphonia |
3.2% |
| Urticaria |
3.2% |
| Deep Vein Thrombosis |
2.9% |
| Pain In Extremity |
2.8% |
| Diarrhoea |
2.2% |
| Fatigue |
2.2% |
| Vision Blurred |
2.2% |
|
| Interacting |
| Dyspnoea |
36.4% |
| Gastric Disorder |
15.2% |
| Smoking Cessation Therapy |
12.1% |
| Chronic Obstructive Pulmonary Disease |
9.1% |
| Arthritis |
6.1% |
| Nervous System Disorder |
6.1% |
| Blood Cholesterol Increased |
3.0% |
| Hypertension |
3.0% |
| Thyroid Disorder |
3.0% |
| Thyroid Hormone Replacement Therapy |
3.0% |
| Thyroxine Therapy |
3.0% |
|
| Cerebrovascular Accident |
50.0% |
| Abdominal Discomfort |
25.0% |
| Tobacco User |
25.0% |
|
